Frontlight ResearchEarly access
Trial site
Cheltenham General Hospital
- 9running trials
- 5closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers5 trials
- Lung cancer3 trials
- Prostate cancer3 trials
- Melanoma2 trials
- Bladder cancer1 trial
- Cervical cancer1 trial
- Chronic kidney disease1 trial
- Colorectal cancer1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Kidney cancer1 trial
- Stroke1 trial
- Phase
- Phase 39 trials
- Phase 22 trials
- Phase 2/31 trial
- Status
- Active, not recruiting8 trials
- Completed5 trials
- Recruiting1 trial
- Lead sponsor
- University College, London3 trials
- Institute of Cancer Research, United Kingdom2 trials
- Janssen Research & Development, LLC2 trials
- Amgen1 trial
- Boehringer Ingelheim1 trial
- and 5 more
Running trials
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
CompARE: Escalating Treatment of Intermediate and High-risk Oropharyngeal Cancer (OPC)
Active, not recruiting
Active, not recruiting
Active, not recruiting
Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Kidney cancer1 recruiting
Closed trials
Recruiting
Completed
EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026